LESS CONJUNCTIVAL INFLAMMATION W/ TRAVATAN-Z THAN WITH XALATAN

Cornea. 27(3):339-343, April 2008.

This study concludes:


"Once-daily dosing of travoprost with sofZia produced significantly fewer corneal changes and less conjunctival inflammation than latanoprost preserved with BAK. Corneal and conjunctival changes noted with travoprost with sofZia were similar to those induced by preservative-free artificial tears."

Comments